Core Viewpoint - Milestone Scientific Inc. will host a conference call to discuss its financial results for Q2 2025 and corporate developments [1] Group 1: Conference Call Details - The conference call is scheduled for 8:00 AM Eastern Time on August 15, 2025 [1] - U.S. callers can dial toll-free 888-506-0062, while international callers can use +1 973-528-0011 with access code 470429 [2] - An audio replay will be available until August 29, 2025, accessible via 877-481-4010 for U.S. callers and +1 919-882-2331 for international callers with access code 52876 [3] Group 2: Company Overview - Milestone Scientific Inc. is a technology-focused medical research and development company specializing in innovative injection technologies for medical, dental, and cosmetic applications [4] - The company’s computer-controlled systems aim to enhance injection precision, efficiency, and patient comfort and safety [4] - The proprietary DPS Dynamic Pressure Sensing Technology is utilized to regulate flow rate and monitor pressure during subcutaneous drug delivery [4]

Core Insights - Milestone Scientific Inc. has appointed Jason Papes as Senior Vice President, Global Head of Sales and Marketing, effective immediately, bringing over 30 years of experience in the healthcare and medical technology sectors [1][2] Company Overview - Milestone Scientific Inc. is a technology-focused medical research and development company that specializes in innovative injection technologies and instruments for medical and dental applications [8] Leadership Experience - Jason Papes has extensive experience in sales, marketing, and business development within the healthcare industry, having held leadership roles at large-cap medical technology companies and entrepreneurial ventures [2][3] - His previous roles include executive positions at Stryker Imaging and Brainlab, where he led significant commercial expansions and market share growth [4] Strategic Initiatives - Papes joins Milestone at a critical time as the company rolls out the CompuFlo® Epidural System, having made progress in establishing procedural payment pathways, including Medicare Part B payment rates under CPT® code 0777T [5] - The company is also advancing growth initiatives in its dental segment, focusing on increasing adoption of the STA Single Tooth Anesthesia® System [6] Leadership Commentary - Eric Hines, CEO of Milestone Scientific, emphasized Papes' leadership experience and understanding of the provider and payer landscape as key assets for the company's growth phase [7] - Papes expressed excitement about joining a team committed to innovation and patient safety, aiming to broaden the company's reach and drive value for stakeholders [7]

Core Insights - Milestone Scientific Inc. has appointed Eric C. Hines as the new Chief Executive Officer, effective immediately, to drive the company's next phase of commercial execution [1][3] Company Overview - Milestone Scientific Inc. is a technology-focused medical research and development company that specializes in innovative injection technologies for medical and dental applications [4] - The company utilizes its proprietary DPS Dynamic Pressure Sensing Technology platform to enhance the precision and efficiency of injections, thereby improving patient comfort and safety [4] Leadership Experience - Eric C. Hines brings over 25 years of leadership experience in scaling sales-driven enterprise software companies, with a notable track record in the healthcare sector [2] - Prior to joining Milestone, Hines served as President of North America at Ex Libris, where he successfully increased annual revenue from approximately $50 million to over $100 million [2] Strategic Goals - The company aims to accelerate the adoption of its CompuFlo technology, which has made significant progress in reimbursement, including Medicare Part B payment rates under CPT code 0777T [3] - Hines expressed a commitment to expanding Milestone's presence in both medical and dental markets, as well as pursuing new clinical indications and global opportunities [3] Market Opportunities - There are compelling opportunities identified in the dental segment, particularly with Milestone's STA system, which is noted for its differentiation in the market [3] - The company is focused on leveraging recent reimbursement achievements to support expanded commercial adoption of its technologies [3]